BNP Paribas Financial Markets’s Sana Biotechnology SANA Stock Holding History

BNP Paribas Financial Markets’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	59,450 +2,332	+4%	+$7.51K	﹤0.01%	4217
2026 Q1	$165K	Buy	57,118 +39,803	+230%	+$157K	﹤0.01%	4136
2025 Q4	$70.5K	Sell	17,315 -50,021	-74%	-$224K	﹤0.01%	4531
2025 Q3	$239K	Buy	67,336 +51,892	+336%	+$188K	﹤0.01%	3925
2025 Q2	$42.2K	Buy	15,444 +4,931	+47%	+$10.2K	﹤0.01%	4321
2025 Q1	$17.7K	Sell	10,513 -10,228	-49%	-$28.6K	﹤0.01%	4571
2024 Q4	$33.8K	Buy	+20,741	New	+$61.9K	﹤0.01%	4572
2022 Q4	–	Sell	-225,732	Closed	-$1.35M	–	4515
2022 Q3	$1.35M	Buy	+225,732	New	+$1.63M	﹤0.01%	2247

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

BNP Paribas Financial Markets's SANA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Sana Biotechnology (SANA) stake by 4.1% in Q2 2026, buying an estimated $7.51K and bringing the position to 59,450 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

BNP Paribas Financial Markets first reported a position in SANA in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.35M in Q3 2022. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

BNP Paribas Financial Markets held 59,450 shares of Sana Biotechnology worth $207K as of Q2 2026.
BNP Paribas Financial Markets bought 2,332 Sana Biotechnology shares in Q2 2026, an estimated $7.51K.
Sana Biotechnology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4217 holding.
BNP Paribas Financial Markets first reported a position in Sana Biotechnology in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Sana Biotechnology position peaked at $1.35M in Q3 2022.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.